Terumo Corp (TRUMY)
16.51
-0.18
(-1.10%)
USD |
OTCM |
Apr 18, 16:00
Terumo Revenue (TTM): 6.302B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.302B |
| September 30, 2023 | 6.205B |
| June 30, 2023 | 6.113B |
| March 31, 2023 | 6.068B |
| December 31, 2022 | 6.085B |
| September 30, 2022 | 6.135B |
| June 30, 2022 | 6.215B |
| March 31, 2022 | 6.261B |
| December 31, 2021 | 6.273B |
| September 30, 2021 | 6.283B |
| June 30, 2021 | 6.144B |
| March 31, 2021 | 5.795B |
| December 31, 2020 | 5.693B |
| September 30, 2020 | 5.608B |
| June 30, 2020 | 5.618B |
| March 31, 2020 | 5.786B |
| December 31, 2019 | 5.744B |
| September 30, 2019 | 5.653B |
| June 30, 2019 | 5.484B |
| March 31, 2019 | 5.407B |
| December 31, 2018 | 5.383B |
| September 30, 2018 | 5.325B |
| June 30, 2018 | 5.361B |
| March 31, 2018 | 5.304B |
| December 31, 2017 | 5.142B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.978B |
| June 30, 2017 | 4.846B |
| March 31, 2017 | 4.745B |
| December 31, 2016 | 4.636B |
| September 30, 2016 | 4.577B |
| June 30, 2016 | 4.467B |
| March 31, 2016 | 4.375B |
| December 31, 2015 | 4.315B |
| September 30, 2015 | 4.325B |
| June 30, 2015 | 4.395B |
| March 31, 2015 | 4.460B |
| December 31, 2014 | 4.587B |
| September 30, 2014 | 4.638B |
| June 30, 2014 | 4.662B |
| March 31, 2014 | 4.662B |
| December 31, 2013 | 4.632B |
| September 30, 2013 | 4.724B |
| June 30, 2013 | 4.782B |
| March 31, 2013 | 4.853B |
| December 31, 2012 | 4.930B |
| September 30, 2012 | 4.919B |
| June 30, 2012 | 4.922B |
| March 31, 2012 | 4.899B |
| December 31, 2011 | 4.686B |
| September 30, 2011 | 4.389B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.484B
Minimum
Jun 2019
6.302B
Maximum
Dec 2023
5.972B
Average
6.085B
Median
Dec 2022
Revenue (TTM) Benchmarks
| Takeda Pharmaceutical Co Ltd | 29.70B |
| Nxera Pharma Co Ltd | 88.33M |
| PeptiDream Inc | 202.69M |
| Stemcell Holdings Inc | 9.984M |
| Healios KK | 0.8776M |